BML-259

Item number	Size	Delivery time	Price
TGM-T36964-5mg	5 mg	7 - 10 business days*	41.00€
TGM-T36964-1mL	1 ml	7 - 10 business days*	46.00€
TGM-T36964-10mg	10 mg	7 - 10 business days*	73.00€
TGM-T36964-25mg	25 mg	7 - 10 business days*	161.00€
TGM-T36964-50mg	50 mg	7 - 10 business days*	276.00€
TGM-T36964-100mg	100 mg	7 - 10 business days*	484.00€
TGM-T36964-500mg	500 mg	7 - 10 business days*	1,032.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively.... more

Close menu

Product information "BML-259"

Description: BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases. Target: CDK. Smiles: CC(C)c1cnc(NC(=O)Cc2ccccc2)s1. References: Kazmierczak A, et al. A novel mechanism of non-Abeta component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5). Neurochem Int. 2011,58(2):206-214.

Keywords:	CAY10554
Supplier:	TargetMol
Supplier-Nr:	T36964

Properties

Application:	CDK5/p25 inhibitor
MW:	260.35 D
Formula:	C14H16N2OS

Database Information

CAS :	267654-00-2\| Matching products
KEGG ID :	K02090 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BML-259"

Write a review